Safety Measures for Maintaining Low Endophthalmitis Rate after Intravitreal Anti-Vascular Endothelial Growth Factor Injection before and during the COVID-19 Pandemic

Safety Measures for Maintaining Low Endophthalmitis Rate after Intravitreal Anti-Vascular Endothelial Growth Factor Injection before and during the COVID-19 Pandemic

During the COVID-19 pandemic, intravitreal injections are performed with patients wearing masks. The risk of endophthalmitis after intravitreal injection is reported to increase due to an influx of exhaled air containing oral bacteria from the upper part of the mask onto the ocular surface. We retro...

Full description

Bibliographic Details
Main Authors: Koji Tanaka, Hiroyuki Shimada, Ryusaburo Mori, Yorihisa Kitagawa, Hajime Onoe, Kazuki Tamura, Hiroyuki Nakashizuka
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Clinical Medicine
Subjects:
adhesive face drape
COVID-19 pandemic
endophthalmitis
intravitreal injection
vascular endothelial growth factor
0.25% povidone-iodine
Online Access:https://www.mdpi.com/2077-0383/11/3/876

Internet

https://www.mdpi.com/2077-0383/11/3/876

Similar Items